N

Novai

22 employees

Novai is a disruptive British biotech start-up with an AI supported retinal biomarker for use in glaucoma and AMD clinical trials.

Basic info

Industry

biotechnology research

Sectors

Glaucoma
Biotechnology
Opthalmology
Biomarker
Age-related Macular Degeneration
Artificial Intelligence
Parkinson's Disease
Pharmaceutical
Clinical Trials
Multiple Sclerosis
Neurodegeneration
Alzheimer's Disease
Drug Development
Retinal

Date founded

2020

Funding rounds raised

Total raised

$2.3M

from 5 investors over 5 rounds

N

Novai raised $1M on January 24, 2023

Investors: SFC Capital

N

Novai raised $2.3M on October 15, 2021

Investors: SFC Capital and Ascension Ventures

N

Novai raised $1.4M on February 17, 2021

Investors: SFC Capital

N

Novai raised $624K on April 15, 2020

Investors: SFC Capital

FAQ